Image

Global Topical Corticosteroids Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Topical Corticosteroids Market, By Molecule Name (Fludroxycortide, Triamcinolone Acetonide, Fluocinolone Acetonide, Antiseptics, Betamethasone, Clobetasone Propionate, Clobetasone Butyrate, Halobetasone, Mometasone, Others), Potency Class (Ultra-High, High,   Moderate, Low), Medication Type (Ointments, Creams, Liquid and Solutions, Lotions, Gel, Oils, Pastes, Sprays, Others), Application (Acne, Dermatitis, Psoriasis, Skin Infection, Hyperpigmentation, Melasma, Others), Distribution Channel (Hospital Pharmacies, Pharmacy Stores, Online Pharmacies, Others), End User (Hospital, Dermatology Clinics, Homecare, Others) – Industry Trends and Forecast to 2029

Topical Corticosteroids Market

Global Topical Corticosteroids Market Analysis and Size

Growing awareness about the benefits of man-made corticosteroids is carving the way for the growth of the market. Increasing advancements in the field of medical science has widened to scope of growth for the topical corticosteroids market.

Data Bridge Market Research analyses that the topical corticosteroids market is expected to undergo a CAGR of 6.60% during the forecast period. This indicates that the market value, which was USD 4.85 billion in 2021, would rocket up to USD 8.08 billion by 2029. “Fludroxycortide” dominates the application segment of the topical corticosteroids market owing to the rising number of inflammatory disorders globally. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Global Topical Corticosteroids Market Definition

Corticosteroids are the steroid hormones which are produced either by the body or synthetically. These hormones are produced by adrenal cortex. Topical corticosteroids are largely used to treat a wide range of inflammatory diseases as these are hydrocortisone-derivative compounds with separate anti-inflammatory potency. When the body or adrenal cortex fails to produce the required corticosteroids, the patients are given synthetic corticosteroids. 

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Molecule Name (Fludroxycortide, Triamcinolone Acetonide, Fluocinolone Acetonide, Antiseptics, Betamethasone, Clobetasone Propionate, Clobetasone Butyrate, Halobetasone, Mometasone, Others), Potency Class (Ultra-High, High,   Moderate, Low), Medication Type (Ointments, Creams, Liquid and Solutions, Lotions, Gel, Oils, Pastes, Sprays, Others),  Application (Acne, Dermatitis, Psoriasis, Skin Infection, Hyperpigmentation, Melasma, Others), Distribution Channel (Hospital Pharmacies, Pharmacy Stores, Online Pharmacies, Others), End User (Hospital, Dermatology Clinics, Homecare, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

GlaxoSmithKline plc (UK), Almirall, S.A (Spain)., Merck & Co., Inc. (Germany), Bausch Health (Canada), Sandoz International GmbH (Germany), Pfizer Inc. (US), AstraZeneca (UK), Sanofi (France), Bayer AG (Germany), McKesson Corporation (US), Regeneron Pharmaceuticals Inc. (US), Allergan (Ireland), Medtronic (Irelenad), AbbVie Inc. (US), GALDERMA LABORATORIES, L.P. (US), Novartis AG (Switzerland), LEO Pharma A/S (Denmark),  Cipla Inc. (US), Johnson & Johnson Services, Inc. (US), Bristol-Myers Squibb Company (US) and Mylan N.V. (US)

Market Opportunities

  • Growth in the awareness about the benefits of synthetic corticosteroids  
  • Increasing incidence rate of arthritis  
  • Rising research and development opportunities

Topical Corticosteroids Market Dynamics

Drivers

  • Rising prevalence of diseases

Growing rate of acute and chronic inflammatory diseases and disorders all around the globe owing to various factors is one of the major factors fostering the growth of the market. For example- growing incidence rate of skin diseases such as rash, dermatitis, itching, eczema, and psoriasis, asthma, allergies and others is directly and positively influencing the growth of the market.

      Research and development proficiencies

Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to the medical instruments and devices will further create lucrative market growth opportunities. Research and development proficiencies being conducted pertaining to inflammatory disorders is also bolstering the market growth rate.

  • Growing investment for healthcare facilities

Surging focus towards improving the condition of healthcare facilities and improving the overall healthcare infrastructure another important factor fostering the growth of the market. Rising number of partnerships and strategic collaborations between the public and private players pertaining to funding and application of new and improved technology is further creating lucrative market opportunities.  

Opportunities

  • Furthermore, upsurge in the public-private funding for target research activities, increase in the incidence of lifestyle-related diseases, high adoption of technologically advanced products, rising geriatric population base and rising product innovations and development owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2022 to 2029. Additionally growth in demand of topical drug delivery drugs, rising internet penetration rate, growing number of mergers and acquisitions and increasing per capita expenditure on health care will further expand the market's growth rate in the future.

Restraints/Challenges Global Topical Corticosteroids Market

On the other hand, high cost associated with the research and development proficiencies, limited infrastructural facilities, uneven distribution of medical services and dearth of awareness in the backward economies are expected to obstruct market growth. Also, lack of favorable reimbursement scenario and technology penetration in the developing economies, decline in the healthcare expenses in the advancing countries, rising patent expiry, pricing pressure by the government, side effects of topical corticosteroids and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2022-2029.

This topical corticosteroids market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the topical corticosteroids market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Topical Corticosteroids Market

COVID-19 gave a push to the market in the upward direction. As topical corticosteroids are highly used in the pharmaceutical industry, it is very useful to treat COVID patients. Rising rate of hospitalization owing to the increasing prevalence of coronavirus infection has further fuelled up the market growth rate. Also, growing application of topical corticosteroids in nasal sprays and medications such as hydrocortisone further induced the growth rate. Moreover, with the rising relaxation post pandemic, the market is expected to grow leaps and bounds.

Global Topical Corticosteroids Market Scope

The topical corticosteroids market is segmented on the basis of molecule name, potency class, medication type, application, distribution channel and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Molecule name

  • Fludroxycortide
  • Triamcinolone Acetonide
  • Fluocinolone Acetonide
  • Antiseptics
  • Betamethasone
  • Clobetasone Propionate
  • Clobetasone Butyrate
  • Halobetasone
  • Mometasone
  • Others

Based on molecule name, the topical corticosteroids market is segmented into fludroxycortide, triamcinolone acetonide, fluocinolone acetonide, antiseptics, betamethasone, clobetasone propionate, clobetasone butyrate, halobetasone, mometasone and others. 

Potency class

  • Ultra-High
  • High
  • Moderate
  • Low

The potency class segment of the topical corticosteroids market is segmented into ultra-high, high, moderate, and low. Ultra-high is further segmented into clobetasol propionate and diflorasone diacetate. High is further segmented into amcinonide, betamethasone dipropionate, desoximetasone, fluocinonide, halcinonide, and others. Moderate is further segmented into desoximetasone, fluocinolone acetonide, fludroxycortide, hydrocortisone valerate, triamcinolone acetonide and others. Low is further segmented into betamethasone valerate, desonide, fluocinolone acetonide, and others.

Medication type

  • Ointments
  • Creams
  • Liquid and Solutions
  • Lotions
  • Gel
  • Oils
  • Pastes
  • Sprays
  • Others

On the basis of medication type, the topical corticosteroids market is segmented into ointments, creams, liquid and solutions, lotions, gel, oils, pastes, sprays and others.

Application

  • Acne
  • Dermatitis
  • Psoriasis
  • Skin Infection
  • Hyperpigmentation
  • Melasma
  • Others

Based on application, the topical corticosteroids market is segmented into acne, dermatitis, psoriasis, skin infection, hyperpigmentation, melasma and others.

Distribution channel

  • Hospital Pharmacies
  • Pharmacy Stores
  • Online Pharmacies
  • Others

On the basis of distribution channel, the topical corticosteroids market is segmented into hospital pharmacies, pharmacy stores, online pharmacies and others.

End user

  • Hospital
  • Dermatology Clinics
  • Homecare
  • Others

The topical corticosteroids market is also segmented on the basis of end user into hospital, dermatology clinics, homecare and others.

Topical Corticosteroids Market Regional Analysis/Insights

The topical corticosteroids market is analysed and market size insights and trends are provided by country, molecule name, potency class, medication type, application, distribution channel and end user as referenced above.

The countries covered in the topical corticosteroids market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the topical corticosteroids market because of the strong base of healthcare facilities, widespread utilization of medications, increase in the expenses in the health care, rapid increase in the prevalence of skin disease, high demand for new topical products for its treatment and rising number of research activities in this region.   

Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, availability of massive untapped markets, large population pool, presence of large number of dermatology clinics and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The topical corticosteroids market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for topical corticosteroids market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the topical corticosteroids market. The data is available for historic period 2010-2020.

Competitive Landscape and Topical Corticosteroids Market Share Analysis

The topical corticosteroids market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to topical corticosteroids market.

Some of the major players operating in the topical corticosteroids market are:

  • GlaxoSmithKline plc (UK)
  • Almirall, S.A (Spain).
  • Merck & Co., Inc. (Germany)
  • Bausch Health (Canada)
  • Sandoz International GmbH (Germany)
  • Pfizer Inc. (US)
  • AstraZeneca (UK)
  • Sanofi (France)
  • Bayer AG (Germany)
  • McKesson Corporation (US)
  • Regeneron Pharmaceuticals Inc. (US)
  • Allergan (Ireland)
  • Medtronic (Ireland)
  • AbbVie Inc. (US)
  • GALDERMA LABORATORIES, L.P. (US)
  • Novartis AG (Switzerland)
  • LEO Pharma A/S (Denmark)
  • Cipla Inc. (US)
  • Johnson & Johnson Services, Inc. (US)
  • Bristol-Myers Squibb Company (US)
  • Mylan N.V. (US)

Research Methodology : Global Topical Corticosteroids Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-topical-corticosteroids-market

Customization Available : Global Topical Corticosteroids Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions

The Topical Corticosteroids Market will be projected at a value of USD 8.08 billion by 2029.
The Topical Corticosteroids Market is Projected to Grow at a CAGR of 6.60% During the Forecast Period of 2022 to 2029.
GlaxoSmithKline plc (UK), Almirall, S.A (Spain)., Merck & Co., Inc. (Germany), Bausch Health (Canada), Sandoz International GmbH (Germany), Pfizer Inc. (US), AstraZeneca (UK), Sanofi (France), Bayer AG (Germany), McKesson Corporation (US), Regeneron Pharmaceuticals Inc. (US), Allergan (Ireland), Medtronic (Irelenad), AbbVie Inc. (US), GALDERMA LABORATORIES, L.P. (US), Novartis AG (Switzerland), LEO Pharma A/S (Denmark), Cipla Inc. (US), Johnson & Johnson Services, Inc. (US), Bristol-Myers Squibb Company (US) and Mylan N.V. (US) are the Major Companies Operating in Topical Corticosteroids Market.
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America are covered in the Topical Corticosteroids Market.
The Topical Corticosteroids Market Report Curated by the Data Bridge Market Research Team Includes In-Depth Expert Analysis, Patient Epidemiology, Pipeline Analysis, Pricing Analysis, and Regulatory Framework.